EMEA-001857-PIP02-20

Key facts

Active substance
Elafibranor
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0295/2020
PIP number
EMEA-001857-PIP02-20
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of primary biliary cholangitis
Route(s) of administration
Oral use
Contact for public enquiries
Genfit SA

Tel.+33 320164000
Email: contact@genfit.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating